Respiratory therapy control based on cardiac cycle

• US 7,967,756 B2
• Filed: 09/15/2004
• Issued: 06/28/2011
• Est. Priority Date: 09/18/2003
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Hartley, Jesse W., Lee, Kent, Ni, Quan
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): MORALES, JON ERIC C
• Application Number:
  US10/943,074
• Publication Number:
  US 20050109339A1
• Time in Patent Office: 2,477 Days
• Field of Search: 600/547, 600/508, 600/509, 600/529
• US Class Current: 600/484
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone

Abstract

Methods and systems involve adjusting respiratory therapy based on cardiac cycle phase. A parameter indicative of cardiac cycle is sensed and the respiratory therapy is adjusted based on cardiac cycle phase. Modulation of respiratory therapy pressure reinforces the pumping action of the heart and results in increased cardiac output with decreased expenditure of myocardial energy output.

Claims

1. A method for delivering airway pressure to a patient, comprising:

providing a patient-implantable cardiac rhythm monitoring system adapted to electrically couple to the patient'"'"'s heart and to communicate with a patient-external respiratory therapy device;

determining cardiac cycle phase using the cardiac rhythm monitoring system, including determining if the cardiac cycle phase is systole or diastole based on one or more of (a) implantably sensing a parameter indicative of the cardiac cycle phase, and (b) determining delivery of a cardiac pacing pulse; and

controlling the airway pressure delivered by the patient-external respiratory therapy device in synchrony with the cardiac cycle phase, wherein controlling the airway pressure is performed at least in part implantably.

2. The method of claim 1, wherein sensing the parameter comprises sensing oxygen saturation.

3. The method of claim 1, wherein sensing the parameter comprises sensing blood pressure.

4. The method of claim 1, wherein sensing the parameter comprises sensing cardiac electrical activity.

5. The method of claim 1, wherein sensing the parameter comprises sensing a parameter associated with cardiac motion.

6. The method of claim 5, wherein sensing the parameter associated with cardiac motion comprises sensing transthoracic impedance.

7. The method of claim 5, wherein sensing the parameter associated with cardiac motion comprises sensing heart sounds.

8. The method of claim 1, wherein implantably controlling the airway pressure comprises matching intrathoracic pressure with cardiac cycle phase.

9. The method of claim 1, wherein implantably controlling the airway pressure comprises:

delivering a first airway pressure during a first cardiac cycle phase; and

delivering a second airway pressure during a second cardiac cycle phase.

10. The method of claim 1, wherein implantably controlling the airway pressure comprises:

modulating airway pressure above a baseline pressure during cardiac systole; and

modulating airway pressure below a baseline pressure during cardiac diastole.

11. The method of claim 1, wherein:

determining the cardiac cycle phase comprises anticipating the cardiac cycle phase; and

implantably controlling the airway pressure comprises controlling the airway pressure based on the anticipated cardiac cycle phase.

12. The method of claim 11, wherein anticipating the cardiac cycle comprises anticipating the cardiac cycle based on recent cardiac cycle history.

13. The method of claim 1, wherein implantably controlling the airway pressure comprises implantably controlling airway pressure to improve at least one of ventricular preload or ventricular afterload.

14. The method of claim 1, wherein implantably controlling the airway pressure comprises implantably controlling the airway pressure to enhance cardiac pumping action.

15. A therapy control system, comprising:

a patient-implantable pulse generator configured to deliver cardiac pacing pulses to a patient'"'"'s heart based on cardiac pacing information;

a patient-implantable cardiac rhythm monitoring system adapted to electrically couple to the patient'"'"'s heart and to communicate with a patient-external respiratory therapy device, the cardiac rhythm monitoring system including a detector system including a sensor configured to implantably sense a parameter associated with cardiac cycle phase, the detector system being configured to determine if the cardiac cycle phase is systole or diastole based on one or more of the sensed parameter and the cardiac pacing information; and

a control unit coupled to the detector system and configured to control airway pressure delivered by the patient-external respiratory therapy device in synchrony with the cardiac cycle phase, wherein the control unit includes at least one implantable component.

16. The system of claim 15, further comprising the patient-external respiratory therapy unit which is configured to deliver an external respiratory therapy to the patient, wherein the implantable control unit is configured to control the delivery of the external respiratory therapy based on the cardiac cycle phase.

17. The system of claim 15, wherein the implantable control unit is configured to match intrathoracic pressure with cardiac cycle.

18. The system of claim 15, wherein the implantable control unit is configured to deliver a first airway pressure during a first cardiac cycle phase and to deliver a second airway pressure during a second cardiac cycle phase.

19. The system of claim 15, wherein the implantable control unit is configured to modulate airway pressure above a baseline pressure during cardiac systole and to modulate airway pressure below a baseline pressure during cardiac diastole.

20. The system of claim 15, wherein:

the detector system is configured to anticipate the cardiac cycle phase; and

the implantable control unit is configured to control the airway pressure based on the anticipated cardiac cycle phase.

21. The system of claim 20, wherein the detector system is configured to store cardiac cycle history and to anticipate the cardiac cycle phase based on the cardiac cycle history.

22. The system of claim 15, wherein the implantable control unit is configured to control the airway pressure comprises to improve at least one of ventricular preload or ventricular afterload.

23. A system for controlling delivery of airway pressure to a patient, comprising:

a patient-implantable pulse generator configured to deliver cardiac pacing pulses to a patient'"'"'s heart based on cardiac pacing information;

patient-implantable cardiac rhythm monitoring system means for electrically coupling to the patient'"'"'s heart and for communicating with a patient-external respiratory therapy device;

means for determining cardiac cycle phase using the cardiac rhythm monitoring system means, the determining means including means for implantably sensing a parameter indicative of cardiac cycle phase, wherein the determining means determines if the cardiac cycle phase is systole or diastole based on one or more of the parameter and the cardiac pacing information; and

means for implantably controlling the airway pressure delivered by the patient-external respiratory therapy device in synchrony with the cardiac cycle phase.